Critical oncology trial data remains hidden: study
01 August, 2022Despite a commitment from the pharmaceutical industry to improve data transparency, more than half of the clinical trials that led to the USFDA approving anticancer medicines over the past 10 years are not available for independent scrutiny.
Combination scans improve outcomes for blood cancer patients
29 June, 2022A Peter Mac-led trial has found that combination PET/CT scans are better at investigating the causes of prolonged fever in blood cancer patients than conventional CT scans.
Partnership to advance oesophageal cancer testing
29 June, 2022QIMR Berghofer has signed an agreement with Proteomics allowing the company to develop and commercialise a blood test for early detection of oesophageal cancer.
Trial to test new strategy for aggresive breast cancer to begin soon
22 June, 2022A clinical trial will use a new strategy to target a 'defence switch' on cancer cells that alerts cancer to the threat of chemotherapy.
Increasing awareness of sun safety
06 June, 2022Skin cancers account for the largest number of newly diagnosed cancers in Australia each year, with incidence of skin cancers being one of the highest in the world.
The role of shared decision-making in cancer treatment
25 May, 2022A patient's perspective on their physical well-being can provide a better indication of their response to cancer treatment than clinician-based tools.
Novel MRI tech for aggressive brain tumours gets funding boost
16 May, 2022The University of South Australia and Ferronova are developing a novel technology to precisely image aggressive brain cancers and guide treatment.
Alarming rise in esophageal cancer cases in middle-aged adults: US study
13 May, 2022Adults aged 45 to 64 experienced a nearly doubled rate of esophageal cancer and a 50% increase in the precancerous condition Barrett’s esophagus between 2012 and 2019, according to a US study.
TROG President receives inaugural NHMRC clinical trials award
19 April, 2022Professor Trevor Leong, President, TROG Cancer Research, has been awarded the inaugural NHMRC David Cooper Clinical Trials and Cohort Studies Award.
Research program to collect real-time PROMs to improve cancer care
08 April, 2022Monash University's registry-based clinical trial, PROpatient, aims to determine if symptom monitoring and care coordination, using digital patient pathways, improve quality of life for cancer patients.
Ivor Lewis esophagectomy surgery performed at Mater Townsville
25 March, 2022The minimally invasive Ivor Lewis esophagectomy surgery has been successfully performed on a patient at Mater Private Hospital Townsville.
How deceased ovarian cancer patients are safeguarding their families' health
21 March, 2022A new Peter Mac-led study has posthumously tested samples from ovarian cancer patients who missed the chance for genetic testing before they died of the disease.
Breast cancer: how often does overdiagnosis occur?
02 March, 2022A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.
Liver cancer: non-invasive treatment trial to begin soon
25 February, 2022A new non-invasive treatment for inoperable early-stage liver cancer is set to be trialled across Australia this year.
Cervical screening tests could help detect ovarian, breast cancers
02 February, 2022Cervical screening tests could be used to find ovarian and breast cancers, according to international researchers.
